ARTICLE | Finance
Public Equity Report: Ideaya, Cartesian raise catalyst-driven deals
Plus: Artiva takes second look at IPO, Moderna gets $176M BARDA award
July 13, 2024 12:47 AM UTC
A quiet two weeks for public market deals saw at least a few catalyst-driven financings get done despite the Independence Day holiday in the U.S.
The biggest deal came from cancer company Ideaya Biosciences Inc. (NASDAQ:IDYA), which raised $302.4 million on July 9 in a follow-on through the sale of 8.4 million shares or pre-funded warrants at $35, a discount of 9% from Ideaya’s $38.62 closing price on July 9, as the deal priced after market. ...